• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GRKs 在止血和血栓形成中的作用。

The Roles of GRKs in Hemostasis and Thrombosis.

机构信息

Cardeza Foundation for Hematologic Research, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Cyrus Tang Hematology Center, Soochow University, Suzhou 215123, China.

出版信息

Int J Mol Sci. 2020 Jul 28;21(15):5345. doi: 10.3390/ijms21155345.

DOI:10.3390/ijms21155345
PMID:32731360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7432802/
Abstract

Along with cancer, cardiovascular and cerebrovascular diseases remain by far the most common causes of death. Heart attacks and strokes are diseases in which platelets play a role, through activation on ruptured plaques and subsequent thrombus formation. Most platelet agonists activate platelets via G protein-coupled receptors (GPCRs), which make these receptors ideal targets for many antiplatelet drugs. However, little is known about the mechanisms that provide feedback regulation on GPCRs to limit platelet activation. Emerging evidence from our group and others strongly suggests that GPCR kinases (GRKs) are critical negative regulators during platelet activation and thrombus formation. In this review, we will summarize recent findings on the role of GRKs in platelet biology and how one specific GRK, GRK6, regulates the hemostatic response to vascular injury. Furthermore, we will discuss the potential role of GRKs in thrombotic disorders, such as thrombotic events in COVID-19 patients. Studies on the function of GRKs during platelet activation and thrombus formation have just recently begun, and a better understanding of the role of GRKs in hemostasis and thrombosis will provide a fruitful avenue for understanding the hemostatic response to injury. It may also lead to new therapeutic options for the treatment of thrombotic and cardiovascular disorders.

摘要

除癌症外,心血管和脑血管疾病仍是目前最常见的死亡原因。心脏病发作和中风是血小板起作用的疾病,通过破裂斑块上的血小板激活和随后的血栓形成。大多数血小板激动剂通过 G 蛋白偶联受体 (GPCR) 激活血小板,这使得这些受体成为许多抗血小板药物的理想靶点。然而,对于提供反馈调节 GPCR 以限制血小板激活的机制知之甚少。我们小组和其他小组的新证据强烈表明,GPCR 激酶 (GRK) 在血小板激活和血栓形成过程中是关键的负调控因子。在这篇综述中,我们将总结 GRK 在血小板生物学中的作用的最新发现,以及特定的 GRK6 如何调节血管损伤的止血反应。此外,我们将讨论 GRK 在血栓性疾病中的潜在作用,例如 COVID-19 患者的血栓事件。关于 GRK 在血小板激活和血栓形成过程中的功能的研究刚刚开始,更好地了解 GRK 在止血和血栓形成中的作用将为理解损伤后的止血反应提供一条富有成效的途径。它也可能为治疗血栓形成和心血管疾病提供新的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42d6/7432802/0f1cea4ded84/ijms-21-05345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42d6/7432802/4cb3be60fe30/ijms-21-05345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42d6/7432802/0f1cea4ded84/ijms-21-05345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42d6/7432802/4cb3be60fe30/ijms-21-05345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42d6/7432802/0f1cea4ded84/ijms-21-05345-g002.jpg

相似文献

1
The Roles of GRKs in Hemostasis and Thrombosis.GRKs 在止血和血栓形成中的作用。
Int J Mol Sci. 2020 Jul 28;21(15):5345. doi: 10.3390/ijms21155345.
2
Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization.GRK6 在通过选择性 G 蛋白偶联受体 (GPCR) 脱敏调节血小板活化中的作用。
Int J Mol Sci. 2020 May 30;21(11):3932. doi: 10.3390/ijms21113932.
3
The GRKs Reactome: Role in Cell Biology and Pathology.GRKs 反应组:在细胞生物学和病理学中的作用。
Int J Mol Sci. 2021 Mar 25;22(7):3375. doi: 10.3390/ijms22073375.
4
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.G 蛋白偶联受体激酶:不只是激酶,也不仅作用于 GPCR。
Pharmacol Ther. 2012 Jan;133(1):40-69. doi: 10.1016/j.pharmthera.2011.08.001. Epub 2011 Aug 26.
5
Chapter Three - Ubiquitination and Protein Turnover of G-Protein-Coupled Receptor Kinases in GPCR Signaling and Cellular Regulation.第三章——G蛋白偶联受体激酶在GPCR信号传导和细胞调节中的泛素化与蛋白质周转
Prog Mol Biol Transl Sci. 2016;141:85-140. doi: 10.1016/bs.pmbts.2016.04.002. Epub 2016 May 7.
6
The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.G蛋白偶联受体激酶在心脏健康与疾病中的演变影响。
Physiol Rev. 2015 Apr;95(2):377-404. doi: 10.1152/physrev.00015.2014.
7
G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets.G 蛋白偶联受体激酶在高血压中的作用:生理、发病机制和治疗靶点。
Hypertens Res. 2024 Sep;47(9):2317-2336. doi: 10.1038/s41440-024-01763-y. Epub 2024 Jul 3.
8
GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.GRK6通过对血小板中GPCR信号传导的限速作用来调节对损伤的止血反应。
Blood Adv. 2020 Jan 14;4(1):76-86. doi: 10.1182/bloodadvances.2019000467.
9
Feedback regulation of G protein-coupled receptor signaling by GRKs and arrestins.GRKs和抑制蛋白对G蛋白偶联受体信号的反馈调节
Semin Cell Dev Biol. 2016 Feb;50:95-104. doi: 10.1016/j.semcdb.2015.12.015. Epub 2016 Jan 7.
10
G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β-adrenergic receptor.G 蛋白偶联受体激酶(GRKs)在β肾上腺素能受体处协调偏激动作用。
Sci Signal. 2018 Aug 21;11(544):eaar7084. doi: 10.1126/scisignal.aar7084.

引用本文的文献

1
The combination of paeonol, diosmetin-7----glucopyranoside, and 5-hydroxymethylfurfural from alleviates arachidonic acid-induced thrombosis in a zebrafish model.来自[具体来源未提及]的丹皮酚、香叶木素-7-O-葡萄糖苷和5-羟甲基糠醛的组合可减轻斑马鱼模型中花生四烯酸诱导的血栓形成。
Front Pharmacol. 2024 Feb 29;15:1332468. doi: 10.3389/fphar.2024.1332468. eCollection 2024.
2
GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12.GRK2 通过 P2Y1 和 P2Y12 调节血小板中的 ADP 信号。
Blood Adv. 2022 Aug 9;6(15):4524-4536. doi: 10.1182/bloodadvances.2022007007.
3
G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1.

本文引用的文献

1
Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19?蛋白酶激活受体 1:在治疗 COVID-19 中的再利用靶点?
Br J Pharmacol. 2020 Nov;177(21):4971-4974. doi: 10.1111/bph.15194. Epub 2020 Jul 27.
2
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.新型冠状病毒肺炎中(微)血栓形成的新威胁及其治疗意义。
Circ Res. 2020 Jul 31;127(4):571-587. doi: 10.1161/CIRCRESAHA.120.317447. Epub 2020 Jun 26.
3
PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153.
G 蛋白偶联受体激酶 5 通过 PAR-1 调节血小板中的凝血酶信号转导。
Blood Adv. 2022 Apr 12;6(7):2319-2330. doi: 10.1182/bloodadvances.2021005453.
4
Comparative Analysis of the Hemostasiological Profile in Sheep and Patients with Cardiovascular Pathology as the Basis for Predicting Thrombotic Risks During Preclinical Tests of Vascular Prostheses.绵羊与心血管病患者止血谱的比较分析,为血管假体临床前试验中血栓风险预测提供依据。
Sovrem Tekhnologii Med. 2021;13(1):52-56. doi: 10.17691/stm2021.13.1.06. Epub 2021 Feb 28.
5
Modulation of Hemostasis in COVID-19; Blood Platelets May Be Important Pieces in the COVID-19 Puzzle.新型冠状病毒肺炎(COVID-19)中止血的调节;血小板可能是COVID-19谜题中的重要部分。
Pathogens. 2021 Mar 19;10(3):370. doi: 10.3390/pathogens10030370.
PAR4 的激活涉及细胞外环 3 和跨膜残基 Thr153。
Blood. 2020 Nov 5;136(19):2217-2228. doi: 10.1182/blood.2019004634.
4
Platelet gene expression and function in patients with COVID-19.新型冠状病毒肺炎患者的血小板基因表达和功能。
Blood. 2020 Sep 10;136(11):1317-1329. doi: 10.1182/blood.2020007214.
5
Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization.GRK6 在通过选择性 G 蛋白偶联受体 (GPCR) 脱敏调节血小板活化中的作用。
Int J Mol Sci. 2020 May 30;21(11):3932. doi: 10.3390/ijms21113932.
6
Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?COVID-19 相关静脉血栓栓塞症:目前我们了解多少?
Acta Haematol. 2020;143(5):417-424. doi: 10.1159/000508233. Epub 2020 May 12.
7
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高:更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
8
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高:一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
9
Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19: Implications From Clinical Features to Pathologic Findings.2019冠状病毒病患者经皮冠状动脉介入治疗后的抗血小板治疗:从临床特征到病理发现的启示
Circulation. 2020 Jun 2;141(22):1736-1738. doi: 10.1161/CIRCULATIONAHA.120.046988. Epub 2020 Apr 16.
10
Mouse laser injury models: variations on a theme.鼠激光损伤模型:万变不离其宗。
Platelets. 2020 May 18;31(4):423-431. doi: 10.1080/09537104.2020.1748589. Epub 2020 Apr 16.